Tri Locum Partners as of June 30, 2023
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 59 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Lilly Eli & Co Unit (LLY) | 9.5 | $26M | 54k | 468.98 | |
| Johnson & Johnson (JNJ) | 7.8 | $21M | 127k | 165.52 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 6.4 | $17M | 1.0M | 16.48 | |
| West Pharmaceutical Services (WST) | 5.8 | $16M | 41k | 382.47 | |
| Regeneron Pharmaceuticals (REGN) | 5.5 | $15M | 21k | 718.54 | |
| Axsome Therapeutics (AXSM) | 5.3 | $14M | 200k | 71.86 | |
| Medtronic SHS (MDT) | 5.3 | $14M | 161k | 88.10 | |
| Reata Pharmaceuticals Cl A | 3.6 | $9.8M | 96k | 101.96 | |
| Catalent (CTLT) | 3.2 | $8.7M | 201k | 43.36 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.2 | $8.7M | 25k | 351.91 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 3.1 | $8.3M | 1.1M | 7.53 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 3.0 | $8.1M | 117k | 69.03 | |
| X4 Pharmaceuticals (XFOR) | 3.0 | $8.0M | 4.1M | 1.94 | |
| Illumina (ILMN) | 2.8 | $7.7M | 41k | 187.49 | |
| Dex (DXCM) | 2.5 | $6.7M | 52k | 128.51 | |
| Inari Medical Ord (NARI) | 2.5 | $6.6M | 113k | 58.14 | |
| Silk Road Medical Inc Common (SILK) | 2.4 | $6.5M | 199k | 32.49 | |
| Madrigal Pharmaceuticals (MDGL) | 2.2 | $6.0M | 26k | 231.00 | |
| Stevanato Group S P A Ord Shs (STVN) | 2.1 | $5.7M | 176k | 32.38 | |
| ImmunoGen | 2.1 | $5.6M | 298k | 18.87 | |
| Praxis Precision Medicines I | 2.1 | $5.6M | 4.9M | 1.15 | |
| Alnylam Pharmaceuticals (ALNY) | 2.1 | $5.6M | 30k | 189.94 | |
| Alpine Immune Sciences (ALPN) | 1.3 | $3.4M | 332k | 10.28 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.2 | $3.2M | 151k | 21.14 | |
| 89bio (ETNB) | 1.2 | $3.1M | 166k | 18.95 | |
| Editas Medicine (EDIT) | 1.1 | $3.1M | 371k | 8.23 | |
| Merus N V (MRUS) | 1.0 | $2.7M | 102k | 26.33 | |
| Natera (NTRA) | 1.0 | $2.6M | 53k | 48.66 | |
| Roivant Sciences SHS (ROIV) | 0.8 | $2.0M | 202k | 10.08 | |
| Ventyx Biosciences (VTYX) | 0.7 | $1.9M | 58k | 32.80 | |
| Astria Therapeutics (ATXS) | 0.7 | $1.9M | 224k | 8.33 | |
| Vera Therapeutics Cl A (VERA) | 0.6 | $1.7M | 109k | 16.05 | |
| Mersana Therapeutics (MRSN) | 0.5 | $1.4M | 428k | 3.29 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.5 | $1.3M | 41k | 31.79 | |
| Pmv Pharmaceuticals (PMVP) | 0.4 | $992k | 158k | 6.26 | |
| Immatics SHS (IMTX) | 0.4 | $947k | 82k | 11.54 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $933k | 24k | 38.50 | |
| Protagonist Therapeutics (PTGX) | 0.3 | $932k | 34k | 27.62 | |
| Mirati Therapeutics | 0.3 | $874k | 24k | 36.13 | |
| Schrodinger (SDGR) | 0.3 | $822k | 17k | 49.92 | |
| Cogent Biosciences (COGT) | 0.3 | $792k | 67k | 11.84 | |
| Cymabay Therapeutics | 0.3 | $773k | 71k | 10.95 | |
| Aldeyra Therapeutics (ALDX) | 0.2 | $613k | 73k | 8.39 | |
| Inhibrx (INBX) | 0.1 | $396k | 15k | 25.96 | |
| Fibrogen Put Option (FGEN) | 0.1 | $331k | 123k | 2.70 | |
| Amphenol Corp Cl A (APH) | 0.1 | $223k | 2.6k | 84.95 | |
| Dover Corporation (DOV) | 0.1 | $223k | 1.5k | 147.65 | |
| Hartford Financial Services (HIG) | 0.1 | $219k | 3.0k | 72.02 | |
| Prudential Financial (PRU) | 0.1 | $217k | 2.5k | 88.22 | |
| Colgate-Palmolive Company (CL) | 0.1 | $208k | 2.7k | 77.04 | |
| Cintas Corporation (CTAS) | 0.1 | $206k | 414.00 | 497.08 | |
| Berkshire Hathaway Inc Del Cl B New (BRK.B) | 0.1 | $201k | 588.00 | 341.00 | |
| Kinder Morgan (KMI) | 0.1 | $178k | 10k | 17.22 | |
| Antero Midstream Corp antero midstream (AM) | 0.1 | $135k | 12k | 11.60 | |
| Rithm Capital Corp Com New (RITM) | 0.0 | $127k | 14k | 9.35 | |
| JetBlue Airways Corporation (JBLU) | 0.0 | $123k | 14k | 8.86 | |
| Viatris (VTRS) | 0.0 | $104k | 10k | 9.98 | |
| Under Armour CL C (UA) | 0.0 | $78k | 12k | 6.71 | |
| Femasys (FEMY) | 0.0 | $57k | 112k | 0.51 |
